US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 0.5991
  • -0.1199-16.68%
Close Apr 4 16:00 ET
  • 0.6300
  • +0.0309+5.16%
Post 19:13 ET
53.74MMarket Cap-1.30P/E (TTM)

Context Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.35%29.92M
-37.83%4.31M
202.59%18.7M
-41.64%3.09M
-42.65%3.82M
68.49%25.07M
78.58%6.93M
52.68%6.18M
50.87%5.29M
93.63%6.67M
Selling and administrative expenses
-0.92%7.22M
9.85%1.79M
10.67%1.88M
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
-General and administrative expense
-0.92%7.22M
9.85%1.79M
10.67%1.88M
-6.96%1.7M
-13.21%1.85M
-6.42%7.29M
-6.11%1.63M
-13.97%1.7M
-7.99%1.83M
1.93%2.13M
Research and development costs
27.66%22.7M
-52.50%2.52M
275.13%16.83M
-59.99%1.38M
-56.49%1.97M
150.77%17.78M
147.19%5.3M
115.89%4.49M
128.11%3.46M
235.53%4.53M
Operating profit
-19.35%-29.92M
37.83%-4.31M
-202.59%-18.7M
41.64%-3.09M
42.65%-3.82M
-68.49%-25.07M
-78.58%-6.93M
-52.68%-6.18M
-50.87%-5.29M
-93.63%-6.67M
Net non-operating interest income expense
174.94%3.2M
329.00%964.04K
328.21%1.24M
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
Non-operating interest income
174.94%3.2M
329.00%964.04K
328.21%1.24M
186.47%840.15K
-57.15%152.35K
112.69%1.16M
-31.46%224.72K
51.08%290.44K
1,277.13%293.27K
5,963.13%355.54K
Other net income (expense)
97.43%-1.43K
105.66%3.48K
-114.00%-2.15K
50.05%-6.11K
24.74%3.35K
88.93%-55.57K
-2,568.41%-61.4K
903.20%15.37K
97.55%-12.23K
316.95%2.69K
Other non- operating income (expenses)
97.43%-1.43K
105.66%3.48K
-114.00%-2.15K
50.05%-6.11K
24.74%3.35K
-2,672.95%-55.57K
-2,568.41%-61.4K
903.20%15.37K
-305,775.00%-12.23K
316.95%2.69K
Income before tax
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Income tax
Net income
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Net income continuous Operations
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Minority interest income
Net income attributable to the parent company
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Basic earnings per share
69.33%-0.46
0
40.54%-0.22
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
Diluted earnings per share
69.33%-0.46
0
40.54%-0.22
87.10%-0.04
42.50%-0.23
-61.29%-1.5
-90.91%-0.42
-54.17%-0.37
-24.00%-0.31
-81.82%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.35%29.92M-37.83%4.31M202.59%18.7M-41.64%3.09M-42.65%3.82M68.49%25.07M78.58%6.93M52.68%6.18M50.87%5.29M93.63%6.67M
Selling and administrative expenses -0.92%7.22M9.85%1.79M10.67%1.88M-6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M
-General and administrative expense -0.92%7.22M9.85%1.79M10.67%1.88M-6.96%1.7M-13.21%1.85M-6.42%7.29M-6.11%1.63M-13.97%1.7M-7.99%1.83M1.93%2.13M
Research and development costs 27.66%22.7M-52.50%2.52M275.13%16.83M-59.99%1.38M-56.49%1.97M150.77%17.78M147.19%5.3M115.89%4.49M128.11%3.46M235.53%4.53M
Operating profit -19.35%-29.92M37.83%-4.31M-202.59%-18.7M41.64%-3.09M42.65%-3.82M-68.49%-25.07M-78.58%-6.93M-52.68%-6.18M-50.87%-5.29M-93.63%-6.67M
Net non-operating interest income expense 174.94%3.2M329.00%964.04K328.21%1.24M186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K
Non-operating interest income 174.94%3.2M329.00%964.04K328.21%1.24M186.47%840.15K-57.15%152.35K112.69%1.16M-31.46%224.72K51.08%290.44K1,277.13%293.27K5,963.13%355.54K
Other net income (expense) 97.43%-1.43K105.66%3.48K-114.00%-2.15K50.05%-6.11K24.74%3.35K88.93%-55.57K-2,568.41%-61.4K903.20%15.37K97.55%-12.23K316.95%2.69K
Other non- operating income (expenses) 97.43%-1.43K105.66%3.48K-114.00%-2.15K50.05%-6.11K24.74%3.35K-2,672.95%-55.57K-2,568.41%-61.4K903.20%15.37K-305,775.00%-12.23K316.95%2.69K
Income before tax -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Income tax
Net income -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Net income continuous Operations -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Minority interest income
Net income attributable to the parent company -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Basic earnings per share 69.33%-0.46040.54%-0.2287.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.4
Diluted earnings per share 69.33%-0.46040.54%-0.2287.10%-0.0442.50%-0.23-61.29%-1.5-90.91%-0.42-54.17%-0.37-24.00%-0.31-81.82%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WINSUNBIO
839729
+29.98%
HIGO
872351
+29.93%
DRIVE
838275
+20.30%
4
Shanghai Menon Animal Nutrition Technology
301156
+20.03%
5
Nanjing Railway New Technology
301016
+20.02%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Trump's comeback to the Office

Following Trump's Policies to Seek Investment Opportunities

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings